Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome

Am J Hematol. 2020 Aug;95(8):E192-E194. doi: 10.1002/ajh.25855. Epub 2020 May 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Chest Syndrome*
  • Antibodies, Monoclonal, Humanized
  • Betacoronavirus
  • COVID-19
  • Child
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab